Isabel Spriet

8.2k total citations
194 papers, 4.2k citations indexed

About

Isabel Spriet is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Isabel Spriet has authored 194 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Epidemiology, 64 papers in Infectious Diseases and 64 papers in Pharmacology. Recurrent topics in Isabel Spriet's work include Antibiotics Pharmacokinetics and Efficacy (58 papers), Antifungal resistance and susceptibility (53 papers) and Pharmaceutical Practices and Patient Outcomes (34 papers). Isabel Spriet is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (58 papers), Antifungal resistance and susceptibility (53 papers) and Pharmaceutical Practices and Patient Outcomes (34 papers). Isabel Spriet collaborates with scholars based in Belgium, Netherlands and United States. Isabel Spriet's co-authors include Johan Maertens, Ludo Willems, Katrien Lagrou, Wouter Meersseman, Joost Wauters, Pieter Annaert, Eric Van Wijngaerden, Eric Verbeken, Ruth Van Daele and Greet Hermans and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Isabel Spriet

173 papers receiving 4.1k citations

Peers

Countries citing papers authored by Isabel Spriet

Since Specialization

Citations

This map shows the geographic impact of Isabel Spriet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Spriet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Spriet more than expected).

Fields of papers citing papers by Isabel Spriet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Spriet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Spriet. The network helps show where Isabel Spriet may publish in the future.

Co-authorship network of co-authors of Isabel Spriet

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Spriet. A scholar is included among the top collaborators of Isabel Spriet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Spriet. Isabel Spriet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Management challenges and outcomes for non-tuberculous mycobacterial pulmonary disease 2024 ·SHILAP Revista de lepidopterología ·Jeroen De Man, Nele Adriaenssens, (unknown), (unknown), Emmanuel André, Isabel Spriet, (unknown), Natalie Lorent	0
2	Ten reasons for the presence of pharmacy professionals in the intensive care unit 2024 ·Intensive Care Medicine ·Cathrine McKenzie, Isabel Spriet, Nicole Hunfeld	5
3	Decreased Kidney Function Explains Higher Vancomycin Exposure in Older Adults 2024 ·Drugs & Aging ·(unknown), Erwin Dreesen, Matthias Gijsen, (unknown), Stefanie Desmet, Johan Flamaing, Lorenz Van der Linden, Isabel Spriet, Jos Tournoy	1
4	Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation study 2024 ·Journal of Antimicrobial Chemotherapy ·(unknown), (unknown), Joost Wauters, Yves Debaveye, Bart Rijnders, Paul E. Verweij, Roger J. M. Brüggemann, Isabel Spriet, Erwin Dreesen	0
5	Evaluation and implementation of optimized antimicrobial dosing strategies in obese and underweight patients 2024 ·Infection ·(unknown), (unknown), (unknown), Matthias Gijsen, Willy Peetermans, Eric Van Wijngaerden, Stefanie Desmet, Katrien Lagrou, Peter Declercq, (unknown), Isabel Spriet	0
6	Human serum albumin: prediction model and reference values for preterm and term neonates 2024 ·Pediatric Research ·(unknown), Annouschka Laenen, (unknown), (unknown), Pieter Vermeersch, Glynis Frans, Gunnar Naulaers, Matthias Gijsen, Erwin Dreesen, Isabel Spriet, Karel Allegaert, Anne Smits	1
7	Physiologically-based pharmacokinetic modelling in sepsis: A tool to elucidate how pathophysiology affects meropenem pharmacokinetics 2024 ·International Journal of Antimicrobial Agents ·(unknown), Neil Parrott, Matthias Gijsen, Isabel Spriet, Lena E. Friberg, Elisabet I. Nielsen	4
8	Simultaneous determination of ceftazidime and pyridine in human plasma by LC-UV 2023 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Isabel Spriet, (unknown), (unknown), Ann Van Schepdael, Erwin Adams	2
9	Bedside check of medication appropriateness (BED-CMA) as a risk-based tool for bedside clinical pharmacy services: A proof-of-concept study at the trauma surgery ward 2023 ·Computational and Structural Biotechnology Journal ·(unknown), (unknown), Peter Declercq, Willem‐Jan Metsemakers, An Sermon, Minne Casteels, Veerle Foulon, (unknown), Isabel Spriet	0
10	Insights into the Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Older Adults with Atrial Fibrillation: A Structured Narrative Review 2023 ·Clinical Pharmacokinetics ·(unknown), (unknown), Erwin Dreesen, Thomas Vanassche, Peter Verhamme, Isabel Spriet, Lorenz Van der Linden, Jos Tournoy	8
11	Unravelling the Hepatic Elimination Mechanisms of Colistin 2023 ·Pharmaceutical Research ·Bing Qi, Matthias Gijsen, (unknown), (unknown), (unknown), (unknown), (unknown), Joost Wauters, Isabel Spriet, Pieter Annaert	1
12	Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function 2022 ·SHILAP Revista de lepidopterología ·Matthias Gijsen, (unknown), Pieter Annaert, Ruth Van Daele, Philippe Meersseman, Yves Debaveye, Joost Wauters, Erwin Dreesen, Isabel Spriet	18
13	Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokinetics 2021 ·Mycoses ·Ruth Van Daele, Yves Debaveye, Robin Vos, Pascal Van Bleyenbergh, Roger J. M. Brüggemann, Erwin Dreesen, (unknown), Henk‐Jan Guchelaar, Pieter Vermeersch, Katrien Lagrou, Isabel Spriet	3
14	Meropenem Stability in Human Plasma at −20 °C: Detailed Assessment of Degradation 2021 ·Antibiotics ·Matthias Gijsen, (unknown), Pieter Annaert, (unknown), Yves Debaveye, Joost Wauters, Peter Slaets, Isabel Spriet	10
15	Recent advances in clearance monitoring of monoclonal antibodies in patients with inflammatory bowel diseases 2021 ·Expert Review of Clinical Pharmacology ·(unknown), Zhigang Wang, Isabel Spriet, Marc Ferrante, Erwin Dreesen	19
16	Liquid chromatographic method to follow‐up ceftazidime and pyridine in portable elastomeric infusion pumps over 24 h 2021 ·Electrophoresis ·(unknown), (unknown), Isabel Spriet, (unknown), Ann Van Schepdael, Erwin Adams	4
17	Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma 2020 ·European Journal of Clinical Pharmacology ·(unknown), Benoit Beuselinck, (unknown), (unknown), Oliver Bechter, Maarten Albersen, Eduard Roussel, Marcella Baldewijns, Jan Tack, Isabel Spriet	10
18	Quantitative determination of colistin A/B and colistin methanesulfonate in biological samples using hydrophilic interaction chromatography tandem mass spectrometry 2020 ·Drug Testing and Analysis ·Bing Qi, Matthias Gijsen, (unknown), (unknown), (unknown), (unknown), (unknown), Joost Wauters, Isabel Spriet, Pieter Annaert	19
19	Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab 2017 ·Acta Clinica Belgica ·(unknown), Thomas Van Cann, Patrick Schöffski, Paul Clement, Oliver Bechter, Isabel Spriet, Ruxandra Coropciuc, Constantinus Politis, (unknown), Joseph Schoenaers, Herlinde Dumez, Patrick Berteloot, Patrick Neven, Kristiaan Nackaerts, Feng Jung Sherida H. Woei-A-Jin, Kevin Punie, Hans Wildiers, Benoit Beuselinck	40
20	Novel LC–MS/MS method for plasma vancomycin: Comparison with immunoassays and clinical impact 2014 ·Clinica Chimica Acta ·Matthijs Oyaert, Nele Peersman, Davy Kieffer, Kathleen Deiteren, Anne Smits, Karel Allegaert, Isabel Spriet, Johan Van Eldere, Jan Verhaegen, Pieter Vermeersch, Steven Pauwels	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact